Study of Aripiprazole (Abilify) in Children With Symptoms of Mania

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Bipolar Disorder
Interventions
DRUG

Aripiprazole

dosing will occur at 2mg, 5mg, 7mg, 10 mg, 12mg, or 15 mg based on weight, side effects and efficacy

DRUG

Placebo

subjects in phase 2 will be randomized to active abilify or placebo

Trial Locations (1)

44106

University Hospitals Case Medical Center, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University Hospitals Cleveland Medical Center

OTHER